86 related articles for article (PubMed ID: 23509157)
21. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG; Fusi N; Sullender M; Hegde M; Vaimberg EW; Donovan KF; Smith I; Tothova Z; Wilen C; Orchard R; Virgin HW; Listgarten J; Root DE
Nat Biotechnol; 2016 Feb; 34(2):184-191. PubMed ID: 26780180
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of essential genes in the human genome.
Wang T; Birsoy K; Hughes NW; Krupczak KM; Post Y; Wei JJ; Lander ES; Sabatini DM
Science; 2015 Nov; 350(6264):1096-101. PubMed ID: 26472758
[TBL] [Abstract][Full Text] [Related]
23. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
24. Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Ceribelli M; Kelly PN; Shaffer AL; Wright GW; Xiao W; Yang Y; Mathews Griner LA; Guha R; Shinn P; Keller JM; Liu D; Patel PR; Ferrer M; Joshi S; Nerle S; Sandy P; Normant E; Thomas CJ; Staudt LM
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11365-70. PubMed ID: 25049379
[TBL] [Abstract][Full Text] [Related]
25. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.
Mathews Griner LA; Guha R; Shinn P; Young RM; Keller JM; Liu D; Goldlust IS; Yasgar A; McKnight C; Boxer MB; Duveau DY; Jiang JK; Michael S; Mierzwa T; Huang W; Walsh MJ; Mott BT; Patel P; Leister W; Maloney DJ; Leclair CA; Rai G; Jadhav A; Peyser BD; Austin CP; Martin SE; Simeonov A; Ferrer M; Staudt LM; Thomas CJ
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2349-54. PubMed ID: 24469833
[TBL] [Abstract][Full Text] [Related]
26. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract][Full Text] [Related]
27. PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis.
Wang Y; Wang J; Chen L; Chen Z; Wang T; Xiong S; Zhou T; Wu G; He L; Cao J; Liu M; Li H; Gu H
Cancer Cell Int; 2023 Dec; 23(1):323. PubMed ID: 38102641
[TBL] [Abstract][Full Text] [Related]
28. Structural surfaceomics reveals an AML-specific conformation of integrin β
Mandal K; Wicaksono G; Yu C; Adams JJ; Hoopmann MR; Temple WC; Izgutdina A; Escobar BP; Gorelik M; Ihling CH; Nix MA; Naik A; Xie WH; Hübner J; Rollins LA; Reid SM; Ramos E; Kasap C; Steri V; Serrano JAC; Salangsang F; Phojanakong P; McMillan M; Gavallos V; Leavitt AD; Logan AC; Rooney CM; Eyquem J; Sinz A; Huang BJ; Stieglitz E; Smith CC; Moritz RL; Sidhu SS; Huang L; Wiita AP
Nat Cancer; 2023 Nov; 4(11):1592-1609. PubMed ID: 37904046
[TBL] [Abstract][Full Text] [Related]
29. Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia.
Ennis S; Conforte A; O'Reilly E; Takanlu JS; Cichocka T; Dhami SP; Nicholson P; Krebs P; Ó Broin P; Szegezdi E
iScience; 2023 Jun; 26(6):106943. PubMed ID: 37332612
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition.
Brattås MK; Hemsing AL; Rye KP; Hatfield KJ; Reikvam H
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499034
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
Yang Y; Bolomsky A; Oellerich T; Chen P; Ceribelli M; Häupl B; Wright GW; Phelan JD; Huang DW; Lord JW; Van Winkle CK; Yu X; Wisniewski J; Wang JQ; Tosto FA; Beck E; Wilson K; McKnight C; Travers J; Klumpp-Thomas C; Smith GA; Pittaluga S; Maric I; Kazandjian D; Thomas CJ; Young RM
Nat Commun; 2022 Sep; 13(1):5469. PubMed ID: 36115844
[TBL] [Abstract][Full Text] [Related]
32. Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia.
Chi SG; Minami Y
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216478
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive assessment of the prognostic role of cell adhesion molecules in acute myeloid leukemia.
Cheng J; Han J; Lin C
Transl Cancer Res; 2020 Dec; 9(12):7605-7618. PubMed ID: 35117360
[TBL] [Abstract][Full Text] [Related]
34. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
Front Immunol; 2021; 12():756231. PubMed ID: 34867994
[TBL] [Abstract][Full Text] [Related]
35. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
[No Abstract] [Full Text] [Related]
36. Actinobacillus pleuropneumoniae exotoxin ApxI induces cell death via attenuation of FAK through LFA-1.
Li SC; Cheng YT; Wang CY; Wu JY; Chen ZW; Wang JP; Lin JH; Hsuan SL
Sci Rep; 2021 Jan; 11(1):1753. PubMed ID: 33462305
[TBL] [Abstract][Full Text] [Related]
37. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM).
Huang Y; Huang X; Cheng C; Xu X; Liu H; Yang X; Yao L; Ding Z; Tang J; He S; Wang Y
BMC Cancer; 2019 Dec; 19(1):1269. PubMed ID: 31888545
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
[TBL] [Abstract][Full Text] [Related]
40. Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia.
Cremer A; Ellegast JM; Alexe G; Frank ES; Ross L; Chu SH; Pikman Y; Robichaud A; Goodale A; Häupl B; Mohr S; Rao AV; Walker AR; Blachly JS; Piccioni F; Armstrong SA; Byrd JC; Oellerich T; Stegmaier K
Cancer Discov; 2020 Feb; 10(2):214-231. PubMed ID: 31771968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
